Trials / Sponsors / Leland Metheny
Leland Metheny
Academic / Other · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis Acute Myelogenous Leukemia, Acute Lymphatic Leukemia, Chronic Myelogenous Leukemia | Phase 2 | 2025-02-25 |
| Withdrawn | Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome | Phase 1 | 2024-12-01 |
| Recruiting | hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma | Phase 2 | 2023-01-20 |
| Withdrawn | Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHD Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD) | Phase 2 | 2022-05-01 |
| Recruiting | Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia Acute Lymphocytic Leukemia | Phase 1 / Phase 2 | 2017-07-31 |
| No Longer Available | Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts. Hematopoietic/Lymphoid Cancer | — | — |